Tiziana Life Sciences Ltd (TLSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 06-2020 | 12-2019 | 06-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,338 | -4,882 | -10,012 | -4,775 | -9,939 |
| Depreciation Amortization | 91 | 29 | 253 | 1 | 16 |
| Other Working Capital | -295 | -2,902 | 285 | -391 | 1,943 |
| Other Operating Activity | 17,207 | 1,472 | 2,678 | 380 | 3,429 |
| Operating Cash Flow | $-11,335 | $-6,284 | $-6,796 | $-4,785 | $-4,551 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -3 | -4 | N/A | 0 |
| Net Acquisitions | -120 | N/A | 0 | N/A | 0 |
| Investing Cash Flow | $-123 | $-3 | $-4 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 75,346 | 15,031 | 1,680 | 3 | 10,041 |
| Financing Cash Flow | $75,346 | $15,031 | $1,680 | $3 | $10,041 |
| Exchange Rate Effect | 1,736 | N/A | 16 | N/A | -249 |
| Beginning Cash Position | 200 | 190 | 5,304 | 5,355 | 64 |
| End Cash Position | 65,824 | 8,934 | 200 | 572 | 5,304 |
| Net Cash Flow | $65,624 | $8,745 | $-5,104 | $-4,783 | $5,240 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,335 | -6,284 | -6,796 | -4,785 | -4,551 |
| Free Cash Flow | -11,335 | -6,284 | -6,796 | -4,785 | -4,551 |